Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
33.64
-0.64 (-1.87%)
At close: Jul 11, 2025, 4:00 PM
33.56
-0.08 (-0.24%)
After-hours: Jul 11, 2025, 7:56 PM EDT
Moderna Employees
Moderna had 5,800 employees as of December 31, 2024. The number of employees increased by 200 or 3.57% compared to the previous year.
Employees
5,800
Change (1Y)
200
Growth (1Y)
3.57%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
13.01B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5,800 | 200 | 3.57% |
Dec 31, 2023 | 5,600 | 1,700 | 43.59% |
Dec 31, 2022 | 3,900 | 1,200 | 44.44% |
Dec 31, 2021 | 2,700 | 1,400 | 107.69% |
Dec 31, 2020 | 1,300 | 470 | 56.63% |
Dec 31, 2019 | 830 | 70 | 9.21% |
Dec 31, 2018 | 760 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MRNA News
- 18 hours ago - Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 - Accesswire
- 1 day ago - FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months - Benzinga
- 1 day ago - Moderna gets full US approval for COVID vaccine in children 6 months and older - Reuters
- 1 day ago - Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax, in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease - Accesswire
- 1 day ago - Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win - Reuters
- 3 days ago - S&P 500 Gains and Losses Today: FICO Shares Plummet; Moderna Stock Rises - Investopedia
- 3 days ago - Moderna stock rallies on HHS lawsuit news: analyst says negative sentiment reversing - Invezz
- 4 days ago - MRNY: Poor Performance Due To Moderna's Decline - Seeking Alpha